Allergic rhinitis, better known as hay fever, is one of the most common chronic illnesses and is estimated to affect 20% or more individuals at some point in time. An allergy can be considered an exaggerated immune response where the body is trying so hard to keep the allergens out that undesirable symptoms such as sneezing, rhinitis, congestion, and wheezing occur.
New Study Shows Further Cost Savings with Allergy Shots
Allergy shots are commonly known in the medical community as immunotherapy. They are one of (if not the) most effective treatments for allergic rhinitis (hay fever), allergic asthma and flying insect allergy.
Immunotherapy (Allergy Shots): The Allergy Partners Way
Allergy immunotherapy, more commonly referred to as allergy shots, is the most effective treatment available for environmental allergies. By reducing your reactions to pollens, pet dander, molds and dust mites, allergy shots reduce symptoms and your need for medication.
SLIT is an alternative method of allergen desensitization in the management of atopic conditions such as asthma and allergic rhinitis, which does not involve a series of injections. The protocol for SLIT involves an allergist determining a patient’s sensitizing allergens, typically by skin testing, followed by small doses of these allergens placed under the tongue daily
Asthma is a common lung disorder in which the inner lining of the small breathing tubes of the lungs, the bronchioles, becomes inflamed and swollen. At times this leads to spasms or narrowing of these tubes. This may cause wheezing, shortness of breath, and/or tightness in the chest. Cough, especially with exercise or in the middle of the night, is particularly common
Recent and exciting changes to our immunotherapy program include the development of a cluster immunotherapy program that allows patients to reach maintenance immunotherapy in as short as four weeks. Allergy Partners is also excited to offer sublingual immunotherapy to appropriate patients. Compared to traditional immunotherapy, sublingual immunotherapy has a reduced risk